SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data showing slower upper-limb decline among Duchenne muscular dystrophy patients treated with deramiocel is driving attention ahead of the FDAs review. Traders largely view the results as supportive of approval and anticipate short-covering, while skeptics caution that the open-label data may not resolve the FDAs concerns.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is drawing attention amid a prolonged selloff and weak share performance, with traders pointing to macro pressure from rising rates and yields as well as concerns about past share dilution, insider sales, and managements communication. The community is split between frustrated bears expecting further weakness and bulls who see the decline as disconnected from the companys growth and view the shares as oversold.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

The U.S. Navys selection of Boeing for the F/A-XX next-generation fighter program is driving attention, with traders viewing the multibillion-dollar award as a boost to its defense business and long-term backlog. Reactions are largely upbeat, though some remain cautious about Boeings execution and ongoing commercial-aircraft issues.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, sparked a sharp rally and drew attention to analyst upgrades. Traders are broadly bullish, while debate centers on profit-taking and possible dilution; short-squeeze talk and hopes for future lung-cancer data remain speculative.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts Copilot overhauladding workplace-focused features, Office integration, coding tools and autonomous agentshas fueled a sharp share-price rebound and breakout talk. Bulls see a stronger enterprise AI opportunity, while skeptics question whether the update will drive meaningful adoption and revenue, and traders remain divided over the rallys staying power.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after the FHFA opened Fannie Mae and Freddie Mac mortgage pricing to VantageScore alongside FICO Classic, raising concerns that cheaper competition could erode FICOs mortgage-scoring share and pricing power. Traders are split between viewing the selloff as an overreaction because FICO remains embedded in lending and seeing a lasting threat to its competitive moat.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

An Edgewater Research warning that AppLovins growth and market-share gains may be nearing a ceiling has fueled selling pressure, with securities class-action allegations adding to concern. Traders are divided: bears point to slowing growth and competition, while bulls cite client expansion and AXON/e-commerce momentum and view the decline as an overreaction; many also complain about volatile trading.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas positive Phase 3 results for Hetlioz in delayed sleep-wake phase disorder are driving attention; the trial met its primary endpoint, and the company plans to discuss the data with the FDA before pursuing an expanded indication. Traders are largely upbeat about the potential new use, though some caution that approval and commercial impact remain uncertain, alongside speculative buyout talk.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention for persistent small-cap underperformance as rising Treasury yields and expectations of further Fed tightening weigh on rate-sensitive, debt-heavy companies, while mega-cap tech remains comparatively resilient. Traders are split between expecting more downside and seeing oversold conditions near support as a potential base; a recovery case generally depends on yields easing.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervos Cape Station geothermal project reaching first power and exporting electricity to the grid is the main catalyst, marking progress toward utility-scale operations. Traders see it as a major validation of the technology, though the weak share-price reaction has prompted sell-the-news sentiment and continued concerns about execution and the capital needed to scale.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GOEX
$GOEX just ripped to a new 52-week high 🚀
Nearly 100% off its low, powered by:
🥇 Gold’s safe-haven demand
🏦 Central bank buying
💵 Dollar weakness
Full breakdown here 👉 
 https://www.zacks.com/stock/news/2746404/gold-mining-etf-goex-hits-a-new-52-week-high?art_rec=home-home-investment_ideas_stocks-ID15-txt-2746404&amp;cid=sm-stocktwits-2-2746404-teaser-10614&amp;ADID=SYND_STOCKTWITS_TWEET_2_2746404_TEASER_10614

Zacks

Pardon Our Interruption

Zacks Research

Global X Funds - Global X Gold Explorers ETF

 just ripped to a new 52-week high 🚀
Nearly 100% off its low, powered by:
🥇 Gold’s safe-haven demand
🏦 Central bank buying
💵 Dollar weakness
Full breakdown here 👉 
 